Skip to main content

Advertisement

Log in

Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (p < 0.001 and p < 0.05). The results showed that the frequency of changes is statistically (p < 0.05 and p < 0.001) more common in patients with PAPS and SAPS than in the control group. Statistically significant difference between the groups was found in superior and inferior mesentery arteries. Analyzing the number of lesions, there was statistically high difference between the patients with one and two lesions than in patients with four or more lesions (p < 0.001), lower difference compared to the patients with three lesions (p < 0.01), while there was low, but yet statistically important difference between the patients with three lesions and those with five or more blood vessel lesions (p < 0.05). Analyzing percentage of diameter stenosis, we established that the lesions in the groups of 0–30% diameter stenosis (DS) and 30–50% DS in patients with PAPS (n = 42) and SAPS (n = 44) are more common than in the control group (n = 18, p < 0.05). Analyzing the qualitative characteristics of plaques, we established significantly higher frequency of soft tissue and mixed lesions than calcified ones in patients with PAPS and SAPS (p < 0.001; p < 0.05). Our study showed that the subclinical manifestation of the changes on visceral arteries is more common in patients with APS. Patients with abdominal pain were those with two or more lesions, and according to our results, majority had PAPS. Because of its safety and accuracy, the method of choice is MDCT angiography in monitoring the progression of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lockshin MD, Sammartino LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000;43:440–3.

    Article  CAS  PubMed  Google Scholar 

  2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  3. Rovensky J. Asheron’s syndrome - catastrophic antipospholipid syndrome. Autoimmun Rev. 2006;6:61–3.

    Article  CAS  PubMed  Google Scholar 

  4. Shoenfeld Y, Sherer Y, Haratz D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001;22:293–5.

    Article  CAS  PubMed  Google Scholar 

  5. Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V. Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis. 2005;64:315–7.

    Article  CAS  PubMed  Google Scholar 

  6. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498.

    Article  CAS  PubMed  Google Scholar 

  7. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. Isr Med Assoc J. 2008;10(1):8–12.

    PubMed  Google Scholar 

  8. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.

    Article  PubMed  Google Scholar 

  9. Krause I, Blank M, Stojanovich L, et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology. 2005;210:749–54.

    Article  CAS  PubMed  Google Scholar 

  10. Jiménez S, García-Criado MA, Tàssies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology. 2005;44:756–61.

    Article  PubMed  Google Scholar 

  11. Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6(6):379–86.

    Article  PubMed  Google Scholar 

  12. Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D. Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev. 2011;10(4):235-7.

  13. Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics. 2004;24(4):1069–86.

    Article  PubMed  Google Scholar 

  14. Laswed T, Rizzo E, Guntern D, Doenz F, Denys A, Schnyder P, et al. Assessment of occlusive arterial disease of abdominal aorta and lower extremities arteries: value of multidetector CT angiography using an adaptive acquisition method. Eur Radiol. 2008;18(2):263–72.

    Article  CAS  PubMed  Google Scholar 

  15. Kaushik S, Federle M, Schur PH, Krishnan M, Silverman SG, Ros PR. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology. 2001;218:768–7.

    Article  CAS  PubMed  Google Scholar 

  16. Beregi JP, Djabbari M, Desmoucelle F, Willoteaux S, Wattinne L, Louvegini S. Popliteal vascular disease: evaluation with spiral CT angiography. Radiology. 1997;203:477–83.

    Article  CAS  PubMed  Google Scholar 

  17. Verbeeck N, Cavez N, Plawny L, Weber J, Lens V. Primary aortic thrombosis: role of enhanced multislice CT demonstrated in three exceptional cases. JBR-BTR. 2014;97(2):76–80.

    CAS  PubMed  Google Scholar 

  18. Suzuki K, Uemura T, Kikuchi M, Ishihara Y, Ichioka S. Acute limb-threatening ischemia associated with antiphospholipid syndrome: a report of two cases. J Foot Ankle Surg. 2016;55(5):976-9.

  19. Padricelli A, Giribono AM, Ferrara D, Spalla F, Bracale U, Del Guercio L, Servillo G, Ruotolo C, Bracale UM. Severe mesenteric ischemia in a pregnant woman with antiphospholipid syndrome. Ann Vasc Surg. 2017;44:415.e11-415.e16.

  20. Paliogiannis P, Ginesu GC, Feo CF, Cossu ML, Pinna A, Farina G, Vidili G, Porcu A. Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity. Ann Ital Chir. 2016;5.

  21. Salaun E, Bartoli MA, Soler R, Khibri H, Ebbo M, Bernit E, et al. Severe symptomatic stenosis of visceral and renal arteries leading primary antiphospholipid syndrome diagnosis. Ann Vasc Surg. 2014;28(7):1796.e9-1796.e13.

    Article  PubMed  Google Scholar 

  22. Crome CR, Rajagopalan S, Kuhan G, and Fluck N. Rare disease. Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Rep. 2012; 2012:

  23. Senatore FJ, McDonald KJ. Gastrointestinal: ischemic gastrointestinal manifestations in a young adult: implicating a rare initial presentation of antiphospholipid syndrome. Gastroenterol Hepatol. 2016;31(8):1381.

    Article  Google Scholar 

  24. Crome CR, Rajagopalan S, Kuhan G, Fluck N. Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Rep. 2012;2012.

  25. Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev. 2009;8(4):281–6.

    Article  PubMed  Google Scholar 

  26. Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, et al. Agreement of duplex ultrasonography vs computed tomography angiography for evaluation of native and in-stent SFA re-stenosis—findings from a randomized controlled trial. Eur J Radiol. 2012;81(9):2265–9.

    Article  PubMed  Google Scholar 

  27. Saponjski J, Stojanovich L, Petrovic J, Saponjski D. The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome. Immunol Res. 2017;65(2):482–6.

    Article  PubMed  Google Scholar 

  28. Nardi P, Pellegrino A, Romagnoli A, Mve Mvondo C, De Propris S, Sperandio M, et al. Multidetector computed tomographic coronary angiography as an alternative to conventional coronary angiography in non-coronary surgical patients. J Cardiovasc Surg. 2011;52(3):429–35.

    CAS  Google Scholar 

  29. Van den Bosch H, Westenberg J, Setz-Pels W, Kersten E, Tielbeek A, Duijm L, Post J, Teijink J, de Roos A. Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study. Int J Cardiovasc Imag. 2016;32(8):1281-8.

  30. Lin YH, Lin HH, Liu HM, Lee CW, Chen YF. Diagnostic performance of CT and MRI on the detection of symptomatic intracranial dural arteriovenous fistula: a meta-analysis with indirect comparison. Neuroradiology. 2016;58(8):753-63.

  31. Cina A, Di Stasi C, Semeraro V, Marano R, Savino G, Iezzi R, et al. Comparison of CT and MR angiography in evaluation of peripheral arterial disease before endovascular intervention. Acta Radiol. 2016;57(5):547–56.

    Article  PubMed  Google Scholar 

  32. Jimenez S, Garcia-Criado A, Tassies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology. 2005;44:756–61.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all patients who participated in this study and our colleagues from many clinics in Serbia. This work was supported by research grant number 175041, issued by the Ministry of Science of the Republic of Serbia.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jovica Saponjski or Dusan Saponjski.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saponjski, J., Stojanovich, L., Saponjski, J. et al. Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels. Immunol Res 65, 1150–1155 (2017). https://doi.org/10.1007/s12026-017-8968-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-017-8968-1

Keywords

Navigation